Phase I/IIa Clinical Trial of Therapeutic Angiogenesis Using Hepatocyte Growth Factor Gene Transfer to Treat Critical Limb Ischemia

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2011-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/ATVBAHA.110.219550PMID 21183732
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia.

  2008cited by this paper
• Results of a Double-Blind, Placebo-Controlled Study to Assess the Safety of Intramuscular Injection of Hepatocyte Growth Factor Plasmid to Improve Limb Perfusion in Patients With Critical Limb Ischemia

  2008cited by this paper
• Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

  2007cited by this paper
• Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy

  2006cited by this paper
• Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia.

  2006cited by this paper
• Treatment with Intramuscular Vascular Endothelial Growth Factor Gene Compared with Placebo for Patients with Diabetes Mellitus and Critical Limb Ischemia: A Double-Blind Randomized Trial

  2006cited by this paper
• Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial.

  2005cited by this paper
• Serum hepatocyte growth factor levels predict long-term clinical outcome after percutaneous coronary revascularization.

  2005cited by this paper
• Safety Evaluation of Clinical Gene Therapy Using Hepatocyte Growth Factor to Treat Peripheral Arterial Disease

  2004cited by this paper
• Claudication of Vascular Endothelial Growth Factor 121 in Patients With Disabling Intermittent Disease : A Phase II Randomized , Double-Blind , Controlled Study of Adenoviral Delivery Regional Angiogenesis With Vascular Endothelial Growth Factor in Peripheral Arterial

  2003cited by this paper
• A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina.

  2003cited by this paper
• Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial.

  2002cited by this paper
• Impairment of collateral formation in Lp(a) transgenic mice : Therapeutic angiogenesis induced by human hepatocyte growth factor (HGF) gene

  2002cited by this paper
• Keita Angiogenesis Induced by Human Hepatocyte Growth Factor Gene Impairment of Collateral Formation in Lipoprotein ( a ) Transgenic Mice : Therapeutic

  2002cited by this paper
• Therapeutic Angiogenesis Induced by Human Hepatocyte Growth Factor Gene in Rat Diabetic Hind Limb Ischemia Model: Molecular Mechanisms of Delayed Angiogenesis in Diabetes

  2001cited by this paper
• Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease

  2001cited by this paper
• Hepatocyte growth factor (HGF) angiogenic gene therapy: promises for cardiovascular diseases

  2001cited by this paper
• Lower-Extremity Edema Associated with Gene Transfer of Naked DNA Encoding Vascular Endothelial Growth Factor

  2000cited by this paper
• Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets

  2000cited by this paper
• Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: downregulation of HGF in response to hypoxia in vascular cells.

  1999cited by this paper
• Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy.

  1999cited by this paper
• Real-Time Quantitative Polymerase Chain Reaction to Assess Gene Transfer

  1999cited by this paper
• Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia.

  1998cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Serum Hepatocyte Growth Factor in Patients with Peripheral Arterial Occlusive Disease

  1998cited by this paper
• Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia.

  1998cited by this paper
• Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results.

  1998cited by this paper
• A novel vascular modulator, hepatocyte growth factor (HGF), as a potential index of the severity of hypertension.

  1998cited by this paper
• A vascular modulator, hepatocyte growth factor, is associated with systolic pressure.

  1996cited by this paper
• Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor

  1996cited by this paper
• Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb.

  1996cited by this paper
• Rapid and sensitive enzyme-linked immunosorbent assay for measurement of HGF in rat and human tissues

  1995cited by this paper
• Standards for evaluating and reporting the results of surgical and percutaneous therapy for peripheral arterial disease.

  1991cited by this paper
• Standards for evaluating and reporting the results of surgical and percutaneous therapy for peripheral arterial disease.

  1991cited by this paper
• Fate of the patient with chronic leg ischaemia. A review article.

  1989cited by this paper
• Suggested standards for reports dealing with lower extremity ischemia.

  1988cited by this paper
• Suggested standards for reports dealing with lower extremity ischemia. Prepared by the Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery.

  1986cited by this paper

• Promoting vascular stability through Src inhibition and Tie2 activation: A model-based analysis

  2025cites this paper
• Compatibility of Hepatocyte Growth Factor, Adipose-Derived Mesenchymal Stem Cells, and Dermal Fillers for the Treatment of Vocal Fold Scar

  2025cites this paper
• Causal effects of primary aldosteronism on inflammation and bone density: evidence from Mendelian randomization, animal, and clinical studies

  2025cites this paper
• Advancements in Gene-Based Therapeutic Angiogenesis for Chronic Limb-Threatening Ischemia

  2025cites this paper
• Seltoplasmid promotes ulcer healing versus placebo for treating patients with chronic limb-threatening ischemia: HOPE CLTI-2 trial.

  2025cites this paper
• Recombinant Human Hepatocyte Growth Factor Plasmids for Treating Patients with Chronic Limb Threatening Ischaemia: A Systematic Review and Meta-analysis.

  2024cites this paper
• Gene therapy for polygenic or complex diseases

  2024cites this paper
• Assessment of Ketamine's Influence on In Vitro Angiogenesis.

  2024cites this paper
• Gene Therapy for Cardiovascular Disease: Clinical Perspectives

  2024cites this paper
• Selective ROCK Inhibitor Enhances Blood Flow Recovery after Hindlimb Ischemia

  2023cites this paper
• Gene Therapeutic Strategies for Peripheral Artery Disease and New Opportunities Provided by Adeno-Associated Virus Vectors.

  2023cites this paper
• A Comprehensive Review on Current Analytical Approaches Used for the Control of Drug Abuse in Sports

  2023cites this paper
• Rescue of murine hind limb ischemia via angiogenesis and lymphangiogenesis promoted by cellular communication network factor 2

  2023cites this paper
• Role of Hypoxia on microRNA-dependant Regulation of HGFA - HGF - c-Met Signalling Pathway in Human Progenitor and Mature Endothelial Cells.

  2022cites this paper
• Rationale and design for the study of recombinant human hepatocyte growth factor plasmid in the treatment of patients with chronic limb-threatening ischemia (HOPE CLTI): randomized, placebo-controlled, double-blind, phase III clinical trials.

  2022cites this paper
• Therapeutic angiogenesis in Buerger’s disease: reviewing the treatment landscape

  2022cites this paper
• Effective treatment of intractable diseases using nanoparticles to interfere with vascular supply and angiogenic process

  2022cites this paper
• New Technologies and Tissue Repair and Regeneration (2): Other Biotherapeutic Technologies

  2021cites this paper
• Regenerative Medicine and Angiogenesis; Focused on Cardiovascular Disease

  2021cites this paper
• Gene therapy for critical limb ischemia: Per aspera ad astra.

  2021cites this paper
• Chronic Pain Management in General and Hospital Practice

  2021cites this paper
• Regenerative effect of platelet-rich plasma in the murine ischemic limbs.

  2021cites this paper
• pUDK-HGF Gene Therapy to Relieve CLI Rest Pain and Ulcer: A Phase II, Double-Blind, Randomized Placebo-Controlled Trial

  2021cites this paper
• Is gene therapy for limb ischemia a reality?

  2020cites this paper
• pUDK-HGF Gene Therapy to Relieve CLI Rest Pain and Ulcers: A Phase II, Double-Blind, Randomized Placebo-Controlled Trial

  2020influential citation
• Terapia gênica de isquemia de membro é uma realidade?

  2020cites this paper
• Progress of Gene Therapy in Cardiovascular Disease

  2020cites this paper
• ATVB IN FOCUS: Peripheral Artery Disease

  2020cites this paper
• Combined Analysis of Clinical Data on HGF Gene Therapy to Treat Critical Limb Ischemia in Japan.

  2020cites this paper
• Vascular Pain

  2020cites this paper
• Hepatoprotective Activity of InlB321/15, the HGFR Ligand of Bacterial Origin, in CCI4-Induced Acute Liver Injury Mice

  2019cites this paper
• Local pharmacological induction of angiogenesis: Drugs for cells and cells as drugs.

  2019cites this paper
• A biomaterials approach for therapeutic angiogenesis

  2019cites this paper
• Introduction to translational research in vascular surgery/medicine

  2019cites this paper
• Treatment of critical limb ischaemia by pIRES/VEGF165/HGF administration.

  2019cites this paper
• Nanomedicines and gene therapy for the delivery of growth factors to improve perfusion and oxygenation in wound healing

  2018cites this paper
• Engineered Biomaterials for Chronic Wound Healing

  2018cites this paper
• CRISPR Craft: DNA Editing the Reconstructive Ladder

  2018cites this paper
• Contemporary Management of Critical Limb Ischemia.

  2018cites this paper
• Plasmid-based gene therapy with hepatocyte growth factor stimulates peripheral nerve regeneration after traumatic injury.

  2018cites this paper
• BUBR1 Insufficiency Is Correlated with eNOS Reduction Experimentally In Vitro and In Vivo, and in Gastric Cancer Tissue

  2018cites this paper
• Review of WADA Prohibited Substances: Limited Evidence for Performance-Enhancing Effects

  2018cites this paper
• Cutting-Edge Enabling Technologies for Regenerative Medicine

  2018cites this paper
• The CIRSE Research Infrastructure: our 5-year experience

  2018cites this paper
• Hepatocyte Growth Factor Gene Therapy for Ischemic Diseases

  2018cites this paper
• A phase I/II exploratory clinical trial for intracordal injection of recombinant hepatocyte growth factor for vocal fold scar and sulcus

  2018cites this paper
• Topical treatment with the bacterium-derived c-Met agonist InlB321/15 accelerates healing in the abrasion wound mouse model

  2018cites this paper
• Growth Factor Delivery Systems for Tissue Engineering and Regenerative Medicine.

  2018cites this paper
• Stem Cell Smart Technology, where are we now and how far we have to go?

  2018cites this paper
• A comparison of the pro-angiogenic potential of human induced pluripotent stem cell derived endothelial cells and induced endothelial cells in a murine model of peripheral arterial disease.

  2017cites this paper
• Stem cell‐based peripheral vascular regeneration

  2017cites this paper
• Therapeutic strategies for cell-based neovascularization in critical limb ischemia

  2017cites this paper
• New Delivery Systems of Stem Cells for Vascular Regeneration in Ischemia

  2017cites this paper
• Therapeutic Angiogenesis for Peripheral Artery Disease

  2017cites this paper
• Delivery of growth factor‐based therapeutics in vascular diseases: Challenges and strategies

  2017cites this paper
• Medical Therapy for Critical Limb Ischemia

  2017cites this paper
• The Long-Term Care of Patients with Critical Limb Ischemia (CLI)

  2017cites this paper
• HGF Gene Therapy for Therapeutic Angiogenesis in Peripheral Artery Disease

  2017cites this paper
• Investigation of Chitosan-based Hydrogels as a Cell Delivery Platform for Adipose-derived Stem/Stromal Cell Transplantation to Promote Angiogenesis in Ischemic Tissues

  2017cites this paper
• Hepatocyte growth factor and alternative splice variants - expression, regulation and implications in osteogenesis and bone health and repair

  2016cites this paper
• Angiogenic properties of human placenta-derived adherent cells and efficacy in hindlimb ischemia.

  2016cites this paper
• Biochemical and Biophysical Cues in Matrix Design for Chronic and Diabetic Wound Treatment

  2016cites this paper
• Cast Tube Assay: A 3-D in vitro assay for visualization and quantification of horizontal chemotaxis and cellular invasion.

  2016cites this paper
• Partial correction of the dwarf phenotype by non-viral transfer of the growth hormone gene in mice: Treatment age is critical.

  2016cites this paper
• The Current State of Critical Limb Ischemia: A Systematic Review.

  2016cites this paper
• Angiogenesis in Peripheral Artery Disease: Focus on Growth Factor Therapy

  2016cites this paper
• Chapitre 23.3 – Artériopathie oblitérante des membres inférieurs : ischémie critique: Diagnostic, exploration, traitement

  2016cites this paper
• Therapeutic angiogenesis induced by human umbilical cord tissue-derived mesenchymal stromal cells in a murine model of hindlimb ischemia

  2016cites this paper
• Instructive Matrix Cues for Tissue Engineering Applications

  2016cites this paper
• Peripheral Arterial Disease

  2016cites this paper
• Current therapies and investigational drugs for peripheral arterial disease

  2016cites this paper
• Therapeutic application of anti-angiogenic nanomaterials in cancers.

  2016cites this paper
• Horizontal gene transfer from macrophages to ischemic muscles upon delivery of naked DNA with Pluronic block copolymers.

  2016cites this paper
• Syndecan‐4 Enhances Therapeutic Angiogenesis after Hind Limb Ischemia in Mice with Type 2 Diabetes

  2016cites this paper
• Long-term results of pl-VEGF165 intramuscular gene transfer in patients with atherosclerotic chronic lower limb ischemia

  2015cites this paper
• Отдаленные результаты применения pl-VEGF165 при хронической ишемии нижних конечностей вследствие облитерирующего атеросклероза

  2015cites this paper
• Nanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia.

  2015cites this paper
• Modulating the vascular response to limb ischemia: angiogenic and cell therapies.

  2015cites this paper
• Role of Macrophages in Muscle Transfection with pDNA/PLURONIC Formulation

  2015influential citation
• Non viral vectors in gene therapy- an overview.

  2015cites this paper
• ТЕРАПЕВТИЧЕСКИЙ АНГИОГЕНЕЗ С ИСПОЛЬЗОВАНИЕМ ФАКТОРОВ РОСТА И КЛЕТОК КОСТНОГО МОЗГА: БИОЛОГИЧЕСКИЕ ОСНОВЫ И ПЕРСПЕКТИВЫ КЛИНИЧЕСКОГО ПРИМЕНЕНИЯ

  2015cites this paper
• Hepatocyte Growth Factor Effects on Mesenchymal Stem Cells Derived from Human Arteries: A Novel Strategy to Accelerate Vascular Ulcer Wound Healing

  2015cites this paper
• Angiogenic and Cell Therapies

  2015cites this paper
• Limb Ischemia: Cardiovascular Diagnosis and Management from Head to Toe

  2015cites this paper
• Отдаленные результаты применения pl-VEGF 165 при хронической ишемии нижних конечностей вследствие облитерирующего атеросклероза

  2015cites this paper
• Therapeutic Angiogenesis in Ischemic Tissues by Growth Factors and Bone Marrow Mononuclear Cells Administration: Biological Foundation and Clinical Prospects.

  2015cites this paper
• [Therapeutic Angiogenesis Using Growth Factors: Current State and Prospects for Development].

  2015cites this paper
• pCMV-vegf165 Intramuscular Gene Transfer is an Effective Method of Treatment for Patients With Chronic Lower Limb Ischemia

  2015cites this paper
• Gene therapy in peripheral artery disease

  2015cites this paper
• Clinical Safety and Preliminary Efficacy of Plasmid pUDK-HGF Expressing Human Hepatocyte Growth Factor (HGF) in Patients with Critical Limb Ischemia.

  2015cites this paper
• Cellular and molecular mechanisms of HGF/Met in the cardiovascular system.

  2015cites this paper
• Therapeutic angiogenesis for critical limb ischemia.

  2014cites this paper
• Pharmacology in Peripheral Arterial Disease: What the Interventional Radiologist Needs to Know

  2014cites this paper
• The role of gerontology in the era of a super-aged society.

  2014cites this paper
• Gene therapy for peripheral arterial disease

  2014cites this paper
• Simultaneous assessment of hepatocyte growth factor and vascular endothelial growth factor in epithelial lining fluid from patients with COPD.

  2014cites this paper
• Beperminogene perplasmid for the treatment of critical limb ischemia

  2014cites this paper
• [The molecular bypass: an established method for revascularisation of non-operable PAD patients or merely a future vision].

  2014cites this paper
• Therapeutic angiogenesis: recent and future prospects of gene therapy in peripheral artery disease.

  2014cites this paper
• A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods

  2014cites this paper